Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17767378 | 0.90 | PAX8 (0.41) | PAX8 | |
| SCHEMBL2223107 | 0.84 | PAX8 (0.38) | PAX8 | |
| SCHEMBL1182041 | 0.84 | PAX8 (0.38) | PAX8 | |
| SCHEMBL9617279 | 0.84 | PAX8 (0.38) | PAX8 | |
| SCHEMBL8937118 | 0.82 | MPI (0.35) | — | |
| SCHEMBL6863025 | 0.82 | MPI (0.35) | — | |
| SCHEMBL9807659 | 0.82 | PAX8 (0.36) | PAX8 | |
| SCHEMBL20889 | 0.82 | PAX8 (0.36) | PAX8 | |
| SCHEMBL2195882 | 0.81 | PAX8 (0.36) | PAX8 | |
| SCHEMBL17767400 | 0.81 | PAX8 (0.36) | PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115141866-B | Preparation method of glucosamine salt | 中国科学院海洋研究所 | 2023-10-31 | — | — | CN | claimed |
| CN-115141866-A | Preparation method of glucosamine salt | 中国科学院海洋研究所 | 2022-10-04 | — | — | CN | claimed |
| US-7138149-B2 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC. (US) | 2006-11-21 | — | — | US | claimed |
| US-20040228884-A1 | Ion-pair delivery system for cosmetic and pharmaceutical compositions | GUPTA SHYAM K (US) | 2004-11-18 | — | — | US | claimed |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC., AN IDAHO CORPORATION | 2004-09-23 | — | — | US | claimed |
| US-20040156873-A1 | Topically Bioavailable Acne and Rosacea Treatment Compositions | GUPTA SHYAM K (US) | 2004-08-12 | — | — | US | claimed |
| US-20040092482-A1 | Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions | GUPTA SHYAM K (US) | 2004-05-13 | — | — | US | claimed |
| US-6713096-B2 | FOR REDUCING PAIN, INFLAMMATION, STIFFNESS, OR DISCOMFORT IN A MAMMAL | MELALEUCA, INC. | 2004-03-30 | — | — | US | claimed |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | MELALEUCA, INC. | 2003-07-31 | — | — | US | claimed |
| US-5681686-A | BASIC ALUMINUM CHLORIDE AND GLUCOSAMINE SALT | IWATSU ELECTRIC CO., LTD (JP) | 1997-10-28 | — | — | US | claimed |
| CN-115141866-B | Preparation method of glucosamine salt | 中国科学院海洋研究所 | 2023-10-31 | — | — | CN | disclosed |
| CN-115141866-A | Preparation method of glucosamine salt | 中国科学院海洋研究所 | 2022-10-04 | — | — | CN | disclosed |
| US-10813868-B2 | Method of improving hair volume | CONOPCO, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| EP-3218062-B1 | METHOD OF IMPROVING HAIR VOLUME | UNILEVER PLC (GB) | 2019-09-18 | — | — | EP | disclosed |
| CN-106137862-B | Composition and cosmetics containing nano Chinese angelica | 南京谷润生物科技有限公司 | 2019-03-08 | — | — | CN | disclosed |
| EP-1452546-A2 | Poly-beta-1,4-N-Acetyglucosamine | MARINE POLYMER TECHNOLOGIES, INC. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20040092482-A1 | Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions | GUPTA SHYAM K (US) | 2004-05-13 | — | — | US | disclosed |
| US-6713096-B2 | FOR REDUCING PAIN, INFLAMMATION, STIFFNESS, OR DISCOMFORT IN A MAMMAL | MELALEUCA, INC. | 2004-03-30 | — | — | US | disclosed |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | MELALEUCA, INC. | 2003-07-31 | — | — | US | disclosed |
| US-5681686-A | BASIC ALUMINUM CHLORIDE AND GLUCOSAMINE SALT | IWATSU ELECTRIC CO., LTD (JP) | 1997-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092482-A1 | Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions | CUTA, HIRA, HARS1 | PAX8 3014/4885 |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | TNF, IL6, IL1B | PAX8 2064/4885 |
| US-10813868-B2 | Method of improving hair volume | NACA, FTH1, FSCN1 | PAX8 1173/4885 |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | IL6, TNF, IL1B | PAX8 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.